척추 감압/견인 기기 : 세계 시장 인사이트, 경쟁 구도 및 시장 예측(2030년)

Spinal Decompression/Traction Devices Market By Type (Manual Spinal Traction, Mechanical Spinal Traction), By Application (Slipped Discs, Degenerative Disc Disease, Herniated Discs, Others), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the growing geriatric population that suffers from age-related spine-related ailments and advancing innovations in product development.

Global Spinal Decompression/Traction Devices Market was valued at USD 3.98 billion in 2023, growing at a CAGR of 4.24% during the forecast period from 2024 to 2030, in order to reach USD 5.09 billion by 2030. The demand for Spinal Decompression/Traction Devices is primarily being boosted by the increasing incidence of spinal cord diseases and spinal cord trauma, the growing geriatric population that suffers from age-related spine-related ailments, advancing innovations in product development, and the significant awareness regarding these products thereby contributes to the growth of the Spinal Decompression/Traction Devices market during the forecast period.

Spinal Decompression/Traction Devices Market Dynamics:

The Spinal Decompression/Traction Devices market is witnessing a growth in product demand owing to various reasons, one of the key factors such as an increase in the incidence of spinal cord diseases and spinal cord injuries (SCI) caused by road injuries or accidents.

According to the 2022 statistics of the Spinal Cord Injuries Australia, a non-government organization, approximately 15,000 of the Australian population suffer from a spinal cord injury (SCI) and traffic crashes contribute to 46% of all the cases whereas, falls contribute to around 36% of all the traumatic SCI cases.

Moreover, as per the World Health Organization factsheet (2023) on road traffic injuries, road traffic injuries are the leading cause of fatality in children and young adults in the age group of 5-29 years across the globe. The same factsheet further stated that about 20-50 million people suffer from non-fatal injuries in road accidents resulting in a disability as a result of their injury.

Road traffic injuries (RTIs) are the leading cause of unintentional injuries, accounting for the greatest proportion of deaths from unintentional injuries worldwide. Injuries of this nature result in orthopedic spinal decompression, as a major corrective treatment course thereby resulting in the increased demand for Spinal Decompression/Traction Devices. The abovementioned facts indicate the growing prevalence and incidence of various spinal disorders such as degenerative disc disease, disc herniation, and back pain among others. As spinal disorders can majorly impact the quality of life of patients, these indications require the use of Spinal Decompression/Traction Devices as one of the key treatment methods.

Therefore, the increase in the number of road traffic spinal injuries is projected to result in the growing demand for Spinal Decompression/Traction products, thereby contributing to the growth of the Spinal Decompression/Traction Devices market during the forecast period.

Moreover, another key factor responsible for the significant adoption of Spinal Decompression/Traction Devices is the growing geriatric population being more prone to develop spinal deformities such as degenerative disc disorders, spinal stenosis, and others. According to the statistics of World Population Ageing 2020 Highlights, globally, the share of the population aged 65 years or over is expected to increase from 9.3 % in 2020 to around 16.0 % in 2050.

Therefore, this may indicate that the growing aging population may result in the higher demand for Spinal Decompression/Traction Devices owing to an increased probability of spinal deformity in geriatric patients, thereby taking the Spinal Decompression/Traction Devices market growth forward during the forecast period.

However, stringent regulatory requirements for product approvals and the high cost of the devices may restrict the Spinal Decompression/Traction Devices market growth.

In addition to the previously mentioned factors, the Spinal Decompression/Traction Devices market witnessed a period of temporary setback owing to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for Spinal Decompression/Traction Devices in the market as the healthcare system guidelines across the globe temporarily focused all their efforts on the management of COVID-19 patient load during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for Spinal Decompression/Traction Devices is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the Spinal Decompression/Traction Devices market during the forecast period.

Spinal Decompression/Traction Devices Market Segment Analysis:

Spinal Decompression/Traction Devices Market By Type (Manual Spinal Traction, Mechanical Spinal Traction), By Application (Slipped Discs, Degenerative Disc Disease, Herniated Discs, Others), By End-User (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the by type segment of the Spinal Decompression/Traction Devices Market, the Manual Spinal Traction category is expected to account for a significant revenue share in 2020 and is expected to remain the same throughout the forecast period. This can be ascribed to their advantageous property that the pain intensity gets significantly reduced among other types of products. Additionally, it is evident that Manual traction techniques combined with mobilization improve pain and manage disability in patients as compared with Mechanical Spinal Traction alone. Furthermore, it has been observed that mechanical traction is a safe treatment but does not provide significant differences in treating chronic neck pain, whereas Manual Spinal Traction effectively treats any part of the spine.

Therefore, the advantages offered by the Manual Spinal Traction in relieving back pain are predicted to contribute to the increasing demand for the Manual Spinal Traction thereby driving the growth of the overall Spinal Decompression/Traction Devices market during the forecast period.

North America is expected to dominate the Overall Spinal Decompression/Traction Devices Market:

Among all the regions, North America is expected to account for the largest share in the Spinal Decompression/Traction Devices market. Owing to significant growth factors such as the rising prevalence of spinal cord disorders like scoliosis and spinal cord injuries, the aging population, and rising government initiatives regarding disease treatment awareness, North America Spinal Decompression/Traction Devices Market is expected to witness positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.

As per the data provided by the National Spinal Cord Injury Statistical Center, the United States in 2020, there are about 17,810 new cases of spinal cord injuries (SCIs) in the country. The factsheet indicated a higher prevalence in males with about 78% of males accounting for new SCI cases.

According to the National Scoliosis Foundation 2018, more than four million people were diagnosed with scoliosis in the United States. Spinal cord conditions like Scoliosis are considered to be one of the key factors responsible for the growth of the Spinal Decompression/Traction Devices market.

According to the National SCI Statistical Center 2018, the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million or about 17,700 new SCI cases each year in the United States.

Therefore, the presence of a large patient population suffering from Scoliosis, Kyphosis correlates to the rising adoption of the Spinal Decompression/Traction Devices which would indicate the growing need for Spinal Decompression/Traction Devices, thereby increasing product demand supporting the growth of the United States Spinal Decompression/Traction Devices market.

Also, the prevalence and incident cases are projected to increase by the time due to the aging worldwide population, who are more prone to musculoskeletal degenerative disorders such as osteoarthritis with the onset of senescence. According to data from World Population Prospects: the 2019 Revision, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Northern America could be aged 65 or over. Also, the number of persons aged 80 years or over was projected to triple, from 143 million in 2019 to 426 million in 2050.

Furthermore, as per the data provided by the US Centers for Disease Control and Prevention (2018), it has been estimated that by 2025, 67 million people in the country will have doctor-diagnosed arthritis and it is expected to reach 78 million by 2045. This increase in the population of the disease affected with arthritis would lead to the increased number of orthopedic surgeries in the country which in turn will contribute to the increasing demand for Spinal Decompression/Traction Devices thereby aiding in the growth of the Spinal Decompression/Traction Devices market in the country and as well as the region.

Moreover, trauma, back pain, and osteoarthritis are the three most common musculoskeletal conditions for which Spinal Decompression/Traction Devices are used extensively. As per the data provided by the United States Bone and Joint Initiative (2023), musculoskeletal diseases affect more than one out of every two persons in the United States age 18 and over, and nearly three out of four age 65 and over. Trauma, back pain, and osteoarthritis are the three most common musculoskeletal conditions reported, and for which health care visits to physicians' offices, emergency departments, and hospitals occur each year. Furthermore, the abovementioned source stated that in any given year, 12% to 14% of the adult population will visit their physician for back pain.

The high presence of musculoskeletal diseases affected the patient population in the country and subsequent treatments with Spinal Decompression/Traction Devices will drive the market growth. Further, it is estimated that there may be an increase in the cases of spinal cord disorders that may, in turn, drive the overall demand for Spinal Decompression/Traction Devices in the United States and across the globe, thereby boosting the growth of the United States Spinal Decompression/Traction Devices market as well as the North America Spinal Decompression/Traction Devices market during the forecast period.

Spinal Decompression/Traction Devices Market Key Companies

Some of the key market players operating in the Spinal Decompression/Traction Devices market include DJO LLC (Colfax Corporation), BTL, Vax-D Medical Technologies, CERT Health Sciences, LLC, Spinal Designs International, Inc., North American Medical Corporation, Spinetronics, LLC, Hill Laboratories Company, Chattanooga, v2uhealth, SEERS Medical Limited, gbo Medizintechnik AG, BIcakcIlar, CHINESPORT S.p.a, Manumed, OG Wellness Technologies Co., Ltd., CORE Medical Equipment, LLC, Satisform, SpineMED Group, Mettler Electronics Corp. and others.

Recent Developmental Activities in the Spinal Decompression/Traction Devices Market

In October 2022, Bioventus announced its complete acquisition of Misonix for an undisclosed amount. The acquisition will accelerate the adoption of its recently launched neXus platform for ultrasonic procedures across spinal decompression using the BoneScalpel, SonaStar for tumor ablation in the cranium, and SonicOne for tissue debridement in chronic wounds.

In September 2018, Teeter, manufacturer of the best-known inversion tables launched the most innovative inversion table ever: the Teeter FitSpine LX9. The new FitSpine series introduces an 8-point suspension system supporting the patented FlexTech(TM) Bed to enhance spinal decompression and back pain relief.

Key Takeaways from the Spinal Decompression/Traction Devices Market Report Study

Market size analysis for current Spinal Decompression/Traction Devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Spinal Decompression/Traction Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Spinal Decompression/Traction Devices Market.

Various opportunities available for the other competitor in the Spinal Decompression/Traction Devices Market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Spinal Decompression/Traction Devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Spinal Decompression/Traction Devices market growth in the coming future?

Target Audience who can be benefited from this Spinal Decompression/Traction Devices Market Report Study

Spinal Decompression/Traction Devices products providers

Research organizations and consulting companies

Spinal Decompression/Traction Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Spinal Decompression/Traction Devices

Various End-users who want to know more about the Spinal Decompression/Traction Devices market and latest technological developments in the Spinal Decompression/Traction Devices market.

Frequently Asked Questions for Spinal Decompression/Traction Devices Market:

1. What are Spinal Decompression/Traction Devices?

Spinal traction devices are deployed in the stabilization and decompression of the spine for the treatment of various spine-related disorders and conditions such as fractures, muscle contracture, bone deformities such as lordosis, kyphosis, and scoliosis. These devices are also used in the treatment of lower back pain and muscle spasms. These devices are also used in preparing patients for surgical procedures such as vertebral compression fracture, endoscopic spine surgery, and others.

2. What is the market for Global Spinal Decompression/Traction Devices?

Global Spinal Decompression/Traction Devices Market was valued at USD 3.98 billion in 2023, growing at a CAGR of 4.24% during the forecast period from 2024 to 2030, in order to reach USD 5.09 billion by 2030.

3. What are the drivers for Global Spinal Decompression/Traction Devices Market?

The demand for Spinal Decompression/Traction Devices is primarily being boosted by The demand for Spinal Decompression/Traction Devices is primarily being boosted by the increasing incidence of spinal cord diseases and spinal cord trauma, the growing geriatric population that suffers from age-related spine-related ailments, advancing innovations in product development, and the significant awareness regarding these products thereby contributing in the growth of the Spinal Decompression/Traction Devices market during the forecast period.

4. Who are the key players operating in the Global Spinal Decompression/Traction Devices Market?

Some of the key market players operating in the Spinal Decompression/Traction Devices market include DJO LLC (Colfax Corporation), BTL, Vax-D Medical Technologies, CERT Health Sciences, LLC, Spinal Designs International, Inc., North American Medical Corporation, Spinetronics, LLC, Hill Laboratories Company, Chattanooga, v2uhealth, SEERS Medical Limited, gbo Medizintechnik AG, BIcakcIlar, CHINESPORT S.p.a, Manumed, OG Wellness Technologies Co., Ltd., CORE Medical Equipment, LLC, Satisform, SpineMED, Mettler Electronics Corp. and others.

5. Which region has the highest share in the Spinal Decompression/Traction Devices market?

North America is expected to dominate the overall Spinal Decompression/Traction Devices market during the forecast period, 2024 to 2030. Owing to significant growth factors such as the rising prevalence of spinal cord disorders like scoliosis and spinal cord injuries, the aging population, and rising government initiatives regarding disease treatment awareness, North America Spinal Decompression/Traction Devices Market is expected to witness positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.

Table of Contents

1.Spinal Decompression/Traction Devices Market Report Introduction

2.Spinal Decompression/Traction Devices Market Executive Summary

• 2.1 Scope of the Study
• 2.2 Market at Glance
• 2.3 Competitive Assessment
• 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1 The United States
• 3.2 Europe
• 3.3 Japan
• 3.4 China

4. Spinal Decompression/Traction Devices Market Key Factors Analysis

• 4.1 Spinal Decompression/Traction Devices Market Drivers
  • 4.1.1 Increasing Incidence of Spinal Cord Diseases and Spinal Cord Trauma
  • 4.1.2 The Growing Geriatric Population that Suffers from Age-Related Spine-Related Ailments
  • 4.1.3 Advancing Innovation in Product Development
• 4.2 Spinal Decompression/Traction Devices Market Restraints and Challenges
  • 4.2.1 Stringent Regulatory Requirements for Product Approvals
  • 4.2.2 High Cost of Devices
• 4.3 Spinal Decompression/Traction Devices Market Opportunities
  • 4.3.1 Untapped Potential of Emerging Markets
  • 4.3.2 Increasing Awareness Regarding these Products

5. Spinal Decompression/Traction Devices Market Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Spinal Decompression/Traction Devices Market

7. Spinal Decompression/Traction Devices Market Layout

• 7.1 By Type
  • 7.1.1 Manual Spinal Traction
  • 7.1.2 Mechanical Spinal Traction
• 7.2 By Application
  • 7.2.1 Slipped Discs
  • 7.2.2 Degenerative Disc Disease
  • 7.2.3 Herniated Discs
  • 7.2.4 Others
• 7.3 By End User
  • 7.3.1 Hospitals
  • 7.3.2 Ambulatory Surgical Centers
  • 7.3.3 Others
• 7.4. By Geography
  • 7.4.1 North America
    • 7.4.1.1 North America Spinal Decompression/Traction Devices Market, by Type
    • 7.4.1.2 North America Spinal Decompression/Traction Devices Market, by Application
    • 7.4.1.3 North America Spinal Decompression/Traction Devices Market, by End User
    • 7.4.1.4 North America Spinal Decompression/Traction Devices Market, by Country
    • 7.4.1.4.1 United States
    • 7.4.1.4.2 Canada
    • 7.4.1.4.3 Mexico
  • 7.4.2 Europe
    • 7.4.2.1 Europe Spinal Decompression/Traction Devices Market, by Type
    • 7.4.2.2 Europe Spinal Decompression/Traction Devices Market, by Application
    • 7.4.2.3 Europe Spinal Decompression/Traction Devices Market, by End User
    • 7.4.2.4 Europe Spinal Decompression/Traction Devices Market, by Country
    • 7.4.2.4.1 France
    • 7.4.2.4.2 Germany
    • 7.4.2.4.3 United Kingdom
    • 7.4.2.4.4 Italy
    • 7.4.2.4.5 Spain
    • 7.4.2.4.6 Russia
    • 7.4.2.4.7 Rest of Europe
  • 7.4.3 Asia-Pacific
    • 7.4.3.1 Asia-Pacific Spinal Decompression/Traction Devices Market, by Type
    • 7.4.3.2 Asia-Pacific Spinal Decompression/Traction Devices Market, by Application
    • 7.4.3.3 Asia-Pacific Spinal Decompression/Traction Devices Market, by End User
    • 7.4.3.4 Asia-Pacific Spinal Decompression/Traction Devices Market, by Country
    • 7.4.3.4.1 China
    • 7.4.3.4.2 Japan
    • 7.4.3.4.3 India
    • 7.4.3.4.4 Australia
    • 7.4.3.4.5 South Korea
    • 7.4.3.4.6 Rest of Asia Pacific
  • 7.4.4 Rest of the World (RoW)
    • 7.4.4.1 RoW Spinal Decompression/Traction Devices Market, by Type
    • 7.4.4.2 RoW Spinal Decompression/Traction Devices Market, by Application
    • 7.4.4.3 RoW Spinal Decompression/Traction Devices Market, by End User
    • 7.4.4.4 RoW Spinal Decompression/Traction Devices Market, by Region
    • 7.4.4.4.1 Middle East
    • 7.4.4.4.2 Africa
    • 7.4.4.4.3 South America

8. Spinal Decompression/Traction Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Spinal Decompression/Traction Devices Market Company and Product Profiles

• 9.1 DJO LLC (Colfax Corporation)
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4 Product Listing
  • 9.1.5. Entropy
• 9.2 BTL
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4 Product Listing
  • 9.2.5. Entropy
• 9.3 Vax-D Medical Technologies
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4 Product Listing
  • 9.3.5. Entropy
• 9.4 CERT Health Sciences, LLC
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4 Product Listing
  • 9.4.5. Entropy
• 9.5 Spinal Designs International, Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4 Product Listing
  • 9.5.5. Entropy
• 9.6 North American Medical Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4 Product Listing
  • 9.6.5. Entropy
• 9.7 Spinetronics, LLC
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4 Product Listing
  • 9.7.5. Entropy
• 9.8 Hill Laboratories Company
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4 Product Listing
  • 9.8.5. Entropy
• 9.9 Chattanooga
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4 Product Listing
  • 9.9.5. Entropy
• 9.10 v2uhealth
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4 Product Listing
  • 9.10.5. Entropy
• 9.11 SEERS Medical Limited
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4 Product Listing
  • 9.11.5. Entropy
• 9.12 gbo Medizintechnik AG
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4 Product Listing
  • 9.12.5. Entropy
• 9.13 BIcakcIlar
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4 Product Listing
  • 9.13.5. Entropy
• 9.14 CHINESPORT S.p.a
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4 Product Listing
  • 9.14.5. Entropy
• 9.15 Manumed
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4 Product Listing
  • 9.15.5. Entropy
• 9.16 OG Wellness Technologies Co., Ltd.
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4 Product Listing
  • 9.16.5. Entropy
• 9.17 CORE Medical Equipment, LLC
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4 Product Listing
  • 9.17.5. Entropy
• 9.18 Satisform
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4 Product Listing
  • 9.18.5. Entropy
• 9.19 SpineMED
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4 Product Listing
  • 9.19.5. Entropy
• 9.20 Mettler Electronics Corp.
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4 Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. PROJECT APPROACH

12. About DelveInsight

13. Disclaimer & Contact Us